EUVIMEDEUVIMED entdecken
Multizentrische Studie

Racial disparity in preoperative C‐reactive protein level for predicting prognosis of patients with non‐metastatic clear cell renal cell carcinoma: INMARC study

Wei Chen iD, Hajime Tanaka iD, Masaki Kobayashi iD, Shohei Fukuda, Akinori Nakayama, Margaret F Meagher, Soichiro Yoshida, Ithaar H Derweesh, Viraj A Master, Akihiro Hirakawa, Yasuhisa Fujii iD, Kazutaka Saito

International Journal of Urology · 2025

DOI: 10.1111/iju.15671 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Urology, 2025. Verfasst von Wei Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Institute of Science Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: C-Reactive Protein, Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

C‐reactive protein (CRP) is a prognostic biomarker for clear cell renal cell carcinoma (ccRCC). However, there may be potential racial heterogeneity in distribution and prognostic impact of CRP level. We investigated potential racial differences in distribution and prognostic impact of preoperative CRP among Asian (AS), African American (AA), and Caucasian (CAUC) patients with non‐metastatic ccRCC (nmccRCC).

Methods

We retrospectively analyzed 1991 nmccRCC cases (AS/AA/CAUC: n = 968/223/800) undergoing nephrectomy from the international multi‐institutional database. We investigated CRP distributions and optimal cut‐off values for predicting recurrence‐free survival (RFS) and overall survival (OS) using Cox regressions for each racial group. Subgroup analyses considered comorbidities, pathological T stage, and Fuhrman grade.

Results

Preoperative CRP distributions differed significantly among the races, with median values of 0.90 mg/L (interquartile range, 0.40–2.33) for AS, 5.00 mg/L (1.98–12.20) for AA, and 3.55 mg/L (1.41–8.48) for CAUC ( p < 0.01). Optimal cut‐off values for RFS were 1.2 mg/L in AS, 2.8 mg/L in AA, and 1.7 mg/L in CAUC, showing C‐indices of 0.77, 0.71, and 0.77, respectively. For OS, they were 1.6 mg/L in AS, 8.3 mg/L in AA, and 9.3 mg/L in CAUC, yielding C‐indices of 0.77, 0.70, and 0.74, respectively. Subgroup analyses revealed varying reference ranges of CRP levels among races (1.1–2.2/2.7–5.0/1.5–3.4 mg/L for RFS, and AS/AA/CAUC: 0.9–3.0/8.0–12.7/8.0–10.4 mg/L for OS, respectively).

Conclusion

The preoperative CRP distributions and their optimal cut‐off values for predicting patient prognosis differed significantly among the races. Using race‐specific cut‐off values, CRP demonstrated consistently high‐prognostic accuracies, which may improve tailored patient management in nmccRCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

C-Reactive ProteinCarcinoma, Renal CellKidney NeoplasmsAgedFemaleHumansMaleMiddle AgedBiomarkers, TumorBlack or African AmericanDisease-Free SurvivalNephrectomyPreoperative PeriodPrognosisRetrospective StudiesWhiteAsian

Stichwörter der Autor:innen

C‐reaction proteinINMARCprognosisracial disparityrenal cell carcinoma

Substanzen

Biomarkers, TumorC-Reactive Protein

Autor:innen und Institutionen

  • Department of Urology, Institute of Science Tokyo, Tokyo, Japan.
  • Department of Urology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.
  • Department of Urology, University of California San Diego School of Medicine, La Jolla, California, USA.
  • Department of Urology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Clinical Biostatistics, Institute of Science Tokyo, Tokyo, Japan.

ORCID-Profile: Wei Chen, Hajime Tanaka, Masaki Kobayashi, Yasuhisa Fujii

Zitieren

APA

Chen, W., Tanaka, H., Kobayashi, M., Fukuda, S., Nakayama, A., Meagher, M. F., Yoshida, S., Derweesh, I. H., Master, V. A., Hirakawa, A., Fujii, Y., & Saito, K. (2025). Racial disparity in preoperative C‐reactive protein level for predicting prognosis of patients with non‐metastatic clear cell renal cell carcinoma: INMARC study. International Journal of Urology. https://doi.org/10.1111/iju.15671

Vancouver

Chen W, Tanaka H, Kobayashi M, Fukuda S, Nakayama A, Meagher MF, et al. Racial disparity in preoperative C‐reactive protein level for predicting prognosis of patients with non‐metastatic clear cell renal cell carcinoma: INMARC study. International Journal of Urology. 2025. doi:10.1111/iju.15671

BibTeX
@article{Chen2025,
  author = {Chen, Wei and Tanaka, Hajime and Kobayashi, Masaki and Fukuda, Shohei and Nakayama, Akinori and Meagher, Margaret F and Yoshida, Soichiro and Derweesh, Ithaar H and Master, Viraj A and Hirakawa, Akihiro and Fujii, Yasuhisa and Saito, Kazutaka},
  title = {Racial disparity in preoperative C‐reactive protein level for predicting prognosis of patients with non‐metastatic clear cell renal cell carcinoma: INMARC study},
  journal = {International Journal of Urology},
  year = {2025},
  doi = {10.1111/iju.15671}
}
Kostenlos starten →